Germany· DE-A57-18def11cb1482436
Laryngomedin N
A medicinal product containing hexamidine diisetionate, registered in Germany by Cassella-Med Gmbh & Co. Kg.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Hexamidine Diisetionate
- Manufacturer
- Cassella-Med Gmbh & Co. Kg
- Country
- Germany (DE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Hexamidine diisetionate in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumDesomedine 0.1 %Bausch + Lomb Ireland
- CzechiaZAMISEPTLaboratoires Thea, Clermont-Ferrand
- FinlandZamiseptLaboratoires Thea
- FranceZAMELINE 1 mg/mL, collyre en solutionTHEA
- SwedenZamisept 1 mg/ml Ögondroppar, lösningLaboratoires THEA
- United StatesPHARMBANNER Anti-Fungal Shampoo.Shenzhen Xinxin Yunhai Technology Co., Ltd.
Authorised across Europe · EMA
The same active substance is authorised in 16 EEA countries. Names it is sold under:
- Belgium · Desomedine, Hexomedine Lösung
- Bulgaria · Замидин
- Czechia · Zamisept
- Denmark · Zamisept
- Finland · Zamisept
- France · Desomedine, Hexamidine Gilbert
- Greece · Zameline
- Iceland · Zameline
- Italy · Zamidine
- Luxembourg · Desomedine, Hexomedine Lösung
- Norway · Zamisept
- Poland · Zamidine
- Portugal · Zamisept
- Romania · Zamidine
- Sweden · Zamisept
- Slovakia · Zamisept
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f4896888-f218-4ee1-a5e2-5106750523e8 GET /v1/drugs/f4896888-f218-4ee1-a5e2-5106750523e8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Oropharyngeal Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Hexamidine Diisetionate",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about hexamidine diisetionate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.